Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults (Q46443097)

22 December 2017

title

Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults (English)

1 reference

22 December 2017

1

Janet E McElhaney

1 reference

22 December 2017

author name string

Jonathan W Hooton

series ordinal

2

1 reference

22 December 2017

Nicola Hooton

series ordinal

3

1 reference

22 December 2017

R Chris Bleackley

series ordinal

4

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

22 December 2017

number of pages

7

1 reference

inferred from page(s)

published in

Vaccine

1 reference

22 December 2017

volume

23

1 reference

22 December 2017

issue

25

1 reference

22 December 2017

page(s)

3294-3300

1 reference

22 December 2017

Reduction in mortality associated with influenza vaccine during 1989-90 epidemic

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

Influenza subunit vaccine: antibody responses to one and two doses of vaccine and length of response, with particular reference to the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

Randomized controlled trial of seroresponses to double dose and booster influenza vaccination in frail elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

Granzyme B: a marker of risk for influenza in institutionalized older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

Th1-Th2: reliable paradigm or dangerous dogma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

Granzyme B: a natural born killer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

Effect of congestive heart failure on humoral and ex vivo cellular immune responses to influenza vaccination in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

The cell-mediated cytotoxic response to influenza vaccination using an assay for granzyme B activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

Cytokine production after influenza vaccination in a healthy elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

Immunization of elderly people with two doses of influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

7 January 2021

inferred from DOI database lookup

Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

7 January 2021

inferred from DOI database lookup

Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.080

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VACCINE.2005.01.080

1 reference

22 December 2017

1 reference

22 December 2017